Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:BWAY OTCMKTS:RDGL NASDAQ:SMTI NYSEAMERICAN:STXS On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeBWAYBrainsway$11.76-0.6%$11.85$6.65▼$13.65$222.23M1.4247,723 shs39,211 shsRDGLAdvanced Medical Isotope$0.13+3.8%$0.12$0.06▼$0.18$58.64M1.091.85 million shs1.14 million shsSMTISanara MedTech$24.80+1.8%$27.66$23.53▼$39.08$220.42M1.2647,803 shs37,206 shsSTXSStereotaxis$2.50+14.2%$2.25$1.54▼$2.72$215M1.51697,203 shs1.12 million shsMetaverse Stocks And Why You Can't Ignore ThemThinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceBWAYBrainsway0.00%+2.53%-6.96%+35.02%+72.43%RDGLAdvanced Medical Isotope0.00%+3.28%+16.53%-4.44%+14.77%SMTISanara MedTech0.00%+2.65%-19.14%-23.46%-8.42%STXSStereotaxis0.00%+12.61%+11.61%+17.37%+38.89%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationBWAYBrainsway2.8692 of 5 stars2.55.00.00.02.40.81.9RDGLAdvanced Medical IsotopeN/AN/AN/AN/AN/AN/AN/AN/ASMTISanara MedTech1.5889 of 5 stars3.51.00.00.00.61.70.6STXSStereotaxis0.1981 of 5 stars0.00.00.00.01.91.70.6Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceBWAYBrainsway 3.00Buy$14.2521.17% UpsideRDGLAdvanced Medical Isotope 0.00N/AN/AN/ASMTISanara MedTech 3.00Buy$49.5099.60% UpsideSTXSStereotaxis 0.00N/AN/AN/ACurrent Analyst Ratings BreakdownLatest RDGL, BWAY, STXS, and SMTI Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails6/9/2025BWAYBrainswayHC WainwrightSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Buy$16.005/15/2025SMTISanara MedTechHC WainwrightSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetBuy ➝ Buy$51.00 ➝ $53.00(Data available from 8/10/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookBWAYBrainsway$41.02M5.42$0.25 per share47.16$3.31 per share3.55RDGLAdvanced Medical Isotope$30K1,954.57N/AN/A($0.02) per share-6.45SMTISanara MedTech$86.67M2.54N/AN/A$4.45 per share5.57STXSStereotaxis$26.92M7.99N/AN/A$0.07 per share35.71Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateBWAYBrainsway$2.92M$0.2058.8073.50N/A9.01%7.35%4.72%8/13/2025 (Estimated)RDGLAdvanced Medical Isotope-$2.91MN/A0.00∞N/A-6,249.02%N/A-149.07%8/11/2025 (Estimated)SMTISanara MedTech-$9.66M-$1.34N/AN/AN/A-12.48%-29.22%-13.20%8/13/2025 (Estimated)STXSStereotaxis-$24.05M-$0.28N/AN/AN/A-73.43%-354.30%-48.87%N/ALatest RDGL, BWAY, STXS, and SMTI EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails8/13/2025Q2 2025BWAYBrainsway$0.07N/AN/AN/A$12.34 millionN/A8/13/2025Q2 2025SMTISanara MedTech-$0.33N/AN/AN/A$25.15 millionN/A5/14/2025Q1 2025SMTISanara MedTech-$0.31-$0.41-$0.10-$0.41$23.48 million$23.43 million5/13/2025Q1 2025BWAYBrainsway$0.02$0.04+$0.02$0.04$11.45 million$11.54 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthBWAYBrainswayN/AN/AN/AN/AN/ARDGLAdvanced Medical IsotopeN/AN/AN/AN/AN/ASMTISanara MedTechN/AN/AN/AN/AN/ASTXSStereotaxisN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioBWAYBrainswayN/A5.034.75RDGLAdvanced Medical IsotopeN/A28.6228.43SMTISanara MedTech1.182.772.54STXSStereotaxisN/A1.070.66Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipBWAYBrainsway30.11%RDGLAdvanced Medical IsotopeN/ASMTISanara MedTech8.10%STXSStereotaxis45.35%Insider OwnershipCompanyInsider OwnershipBWAYBrainsway19.00%RDGLAdvanced Medical Isotope18.50%SMTISanara MedTech42.60%STXSStereotaxis17.77%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableBWAYBrainsway12018.90 million15.31 millionNot OptionableRDGLAdvanced Medical Isotope1454.55 million370.46 millionNot OptionableSMTISanara MedTech608.89 million5.10 millionNot OptionableSTXSStereotaxis13086.00 million70.72 millionNot OptionableRDGL, BWAY, STXS, and SMTI HeadlinesRecent News About These CompaniesStereotaxis, Inc. (STXS) Q2 2025 Earnings Call TranscriptAugust 8 at 2:10 PM | seekingalpha.comStereotaxis Inc. (STXS) Reports Q2 Loss, Tops Revenue EstimatesAugust 7 at 6:40 PM | zacks.comStereotaxis Reports 2025 Second Quarter Financial ResultsAugust 7 at 4:01 PM | globenewswire.comWarberg Asset Management LLC Acquires 275,784 Shares of Stereotaxis Inc. (NYSEAMERICAN:STXS)August 4, 2025 | marketbeat.comWill Stereotaxis Inc. (STXS) Report Negative Earnings Next Week? What You Should KnowJuly 31, 2025 | zacks.comStereotaxis (STXS) to Release Earnings on ThursdayJuly 31, 2025 | marketbeat.comStereotaxis (STXS) Gets a Buy from TD CowenJuly 30, 2025 | theglobeandmail.comEssex Investment Management Co. LLC Buys 343,130 Shares of Stereotaxis Inc. (NYSEAMERICAN:STXS)July 29, 2025 | marketbeat.comStereotaxis, Inc.: Stereotaxis Receives U.S. FDA Clearance for MAGiC Sweep CatheterJuly 28, 2025 | finanznachrichten.deStereotaxis Wins FDA Nod for CatheterJuly 28, 2025 | baystreet.caStereotaxis stock soars after FDA clearance for robotic mapping catheterJuly 28, 2025 | za.investing.comStereotaxis gets FDA green light for robotic electrophysiology mapping catheterJuly 28, 2025 | massdevice.comStereotaxis shares jump after FDA approves robotic mapping catheterJuly 28, 2025 | msn.comStereotaxis Receives U.S. FDA Clearance for MAGiC Sweep CatheterJuly 28, 2025 | globenewswire.comStereotaxis to Report Second Quarter 2025 Financial Results on August 7, 2025July 23, 2025 | globenewswire.comStereotaxis (NYSEAMERICAN:STXS) Stock Price Down 2.5% - What's Next?July 19, 2025 | marketbeat.comStereotaxis announces $12.5M offeringJuly 18, 2025 | massdevice.comStereotaxis Sinks on Common Stock OfferingJuly 17, 2025 | baystreet.caStereotaxis Announces $12.5 Million Registered Direct Offering of Common StockJuly 17, 2025 | globenewswire.comStereotaxis, Inc. (STXS) - Yahoo FinanceJuly 10, 2025 | finance.yahoo.comStereotaxis Publishes Positive Results from MAGiC Catheter StudyJuly 10, 2025 | msn.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeRDGL, BWAY, STXS, and SMTI Company DescriptionsBrainsway NASDAQ:BWAY$11.76 -0.07 (-0.59%) Closing price 08/8/2025 04:00 PM EasternExtended Trading$11.78 +0.02 (+0.17%) As of 08/8/2025 05:54 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.BrainsWay Ltd. develops and sells noninvasive neurostimulation treatments for mental health disorders in the United States and internationally. It offers Deep Transcranial Magnetic Stimulation platform technology for the treatment of major depressive disorders, anxious depression, obsessive-compulsive disorders, smoking addiction, bipolar disorders, post traumatic stress disorders, schizophrenia, Alzheimer's disease, autism, chronic pain, multiple sclerosis, post stroke rehabilitation, and Parkinson's diseases. The company serves doctors, hospitals, and medical centers in the field of psychiatry. BrainsWay Ltd. was founded in 2003 and is headquartered in Jerusalem, Israel.Advanced Medical Isotope OTCMKTS:RDGL$0.13 +0.00 (+3.78%) As of 08/8/2025 03:59 PM EasternVivos Inc., a radiation oncology medical device company, develops brachytherapy devices for the treatment of non-resectable tumors in the United States. It develops yttrium-90 based RadioGel device, an injectable particle-gel for brachytherapy radiation treatment of cancerous tumors in people and animals; and IsoPet for the treatment of solid tumors in animals. The company was formerly known as Advanced Medical Isotope Corporation and changed its name to Vivos Inc. in December 2017. Vivos Inc. was incorporated in 1994 and is headquartered in Richland, Washington.Sanara MedTech NASDAQ:SMTI$24.80 +0.44 (+1.81%) Closing price 08/8/2025 04:00 PM EasternExtended Trading$24.68 -0.12 (-0.50%) As of 08/8/2025 05:00 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Sanara MedTech Inc., a medical technology company, develops, markets, and distributes surgical, wound, and skincare products and services to physicians, hospitals, clinics, and post-acute care settings in the United States. The company offers CellerateRX Surgical, a medical hydrolysate of Type I bovine collagen indicated for the management of surgical, traumatic, and partial- and full-thickness wounds, as well as first- and second-degree burns; and HYCOL, a medical hydrolysate of Type I bovine collagen intended for the management of full and partial thickness wounds, including pressure ulcers, venous and arterial leg ulcers, and diabetic foot ulcers. It also provides BIAKOS Antimicrobial Skin and Wound Cleanser, a patented product that contains synergistic ingredients that have been shown to impact mature biofilm microbes; BIAKOS Antimicrobial Wound Gel, an antimicrobial hydrogel wound dressing that helps against planktonic microbes, as well as immature and mature biofilms; and BIAKOS Antimicrobial Skin and Wound Irrigation Solution. In addition, it develops BIASURGE, a no-rinse surgical solution used for wound irrigation; FORTIFY TRG, a freeze-dried, multi-layer small intestinal submucosa extracellular matrix sheet; FORTIFY FLOWABLE extracellular matrix, an advanced wound care device; TEXAGEN, a multi-layer amniotic membrane allograft used as an anatomical barrier with robust handling that can be sutured for securement; and VIM Amnion Matrix, a homologous wound covering product. Sanara MedTech Inc. was incorporated in 2001 and is based in Fort Worth, Texas.Stereotaxis NYSEAMERICAN:STXS$2.50 +0.31 (+14.16%) Closing price 08/8/2025 04:10 PM EasternExtended Trading$2.49 -0.01 (-0.40%) As of 08/8/2025 07:51 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Stereotaxis, Inc. designs, manufactures, and markets robotic systems, instruments, and information systems for the interventional laboratory in the United States and internationally. Its robotic magnetic navigation (RMN) systems include the Genesis RMN and Niobe systems, which enable physicians to complete complex interventional procedures by providing image-guided delivery of catheters and guidewires through the blood vessels and chambers of the heart to treatment sites. The company provides Odyssey, a real-time information solution to manage, control, record, and share procedures across networks; and Stereotaxis Imaging Model S X-ray system, a single-plane, full-power x-ray system, including c-arm, powered table, motorized boom, and monitors for a robotic interventional operating room. In addition, it offers disposables and other accessories, such as QuikCAS automated catheter advancement disposables for the remote advancement of electrophysiology catheters. Further, the company provides Vdrive, a system that offers navigation and stability for the diagnostic and therapeutic devices designed to improve interventional procedures; and V-Loop, V-Sono, and V-CAS disposable components. It markets its products through direct sales force, distributors, and sales agents. The company has a strategic collaboration with MAGiC catheter for cardiac ablation procedures. Stereotaxis, Inc. was incorporated in 1990 and is based in Saint Louis, Missouri. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas MarketBeat Week in Review – 08/04 - 08/08 Rocket Lab Reports Q2 Results: Is the Bull Thesis Still Intact? Airbnb Beats Earnings, But the Growth Story Is Losing Altitude Dutch Bros Just Flipped the Script With a Massive Earnings Beat Amazon Takes an Equity Stake in IonQ—Any Upside Potential? D-Wave Delivers Growth Shock—Investors Eye Quantum Future Is Eli Lilly’s 14% Post-Earnings Slide a Buy-the-Dip Opportunity? Constellation Energy’s Earnings Beat Signals a New Era Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
